Korean J Urol. 2013 Aug;54(8):555-557. English.
Published online Aug 07, 2013.
© The Korean Urological Association, 2013
Case Report

Squamous Cell Carcinoma in Exstrophy of the Bladder

Pramod Kumar Sharma, Praveen Kumar Pandey, Mukesh Kumar Vijay, Malay Kumar Bera, Jitendra Pratap Singh and Kaushik Saha1
    • Department of Urology, Institute of Post Graduate Medical Education and Research, Kolkata, India.
    • 1Department of Pathology, Institute of Post Graduate Medical Education and Research, Kolkata, India.
Received November 21, 2011; Accepted December 08, 2011.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Exstrophy of the bladder is a rare congenital anomaly with an incidence of about 1 per 50,000 newborns. The malignant potential of the exstrophied bladder mucosa is well known; 95% are adenocarcinomas, and 3% to 5% are squamous cell carcinomas. Most of the malignant tumors (60%) associated with an exstrophy of the bladder occur during the fourth and fifth decades of life. Of the remaining, about 20% each occur after 60 years and before 40 years. Here we present a case in which squamous cell carcinoma developed in an unrepaired exstrophy of the bladder. We present the management of the case and a brief review of the literature.

Keywords
Bladder exstrophy; Squamous cell carcinoma; Urinary bladder neoplasms

INTRODUCTION

Exstrophy of the bladder is a rare congenital anomaly. With the development of new techniques for repair, the quality of life of patients with exstrophy of the bladder has been markedly improved. However, it is now well recognized that exstrophy of the bladder is associated with an increased risk of bladder cancer. Here we present a case in which squamous cell carcinoma developed in the exstrophied bladder mucosa.

CASE REPORT

The patient, a 36-year-old woman with a known case of exstrophy of the bladder had undergone repair of the defect 17 years previously. However, dehiscence of the repair had occurred and the patient continued to leak urine from the lower abdominal wall. Six months following this, an ileal conduit urinary diversion was done to prevent the continuous leakage of urine. Six month prior to presentation, the patient had noticed an irregular mass arising from the exposed bladder mucosa that was rapidly increasing in size. On examination, a hemispherical growth with an irregular surface was seen in the region of the exposed bladder mucosa (Fig. 1). The computed tomography scan showed a mildly enhancing nodular lesion on the right side of the lower abdomen superficially. The lesion was confined to the urinary bladder. A wedge biopsy was taken from the growth, and the results were suggestive of squamous cell carcinoma. The results of a routine hematological evaluation, liver function tests, and a chest radiograph were normal. The patient thus underwent removal of the urinary bladder along with a cuff of the surrounding abdominal wall and pelvic lymph node dissection (radical cystectomy). After resection, there was a full thickness defect of the lower abdomen about 8 cm×9 cm in size. To cover this defect, the peritoneum was mobilized on both sides and was sutured in the midline. Both recti were also mobilized and sutured in the midline. The skin defect was resurfaced with an extended groin flap from the left side and the secondary defect thus created was covered by a split thickness skin graft (Figs. 2, 3). Histopathological examination of the resected specimen was suggestive of well-differentiated squamous cell carcinoma infiltrating the underlying muscle (stage pT2a) with dense lymphocytic infiltration of the stroma. All the resected margins and deeper plane of resection were free of tumor (Fig. 4). In the postoperative period, the patient developed a small collection beneath the flap that was drained by removal of two stitches, and daily dressings were done. This site granulated well and healed without any significant additional scaring. The patient is on regular follow-up and is doing well without any evidence of recurrence to date (5 months postoperatively) (Fig. 5).

FIG. 1
Preoperative photograph of the patient showing the hemispherical growth with an irregular surface.

FIG. 2
Intraoperative photograph showing the skin incision used for the modified groin flap.

FIG. 3
Immediate postoperative photograph showing the abdominal wall defect covered with a modified groin flap.

FIG. 4
Photograph of the patient after 5 months of follow-up showing a well-healed modified groin flap and excellent take of the skin graft at the secondary defect site.

FIG. 5
Histopathological picture of the case (H&E, ×400) showing well-differentiated squamous cell carcinoma.

DISCUSSION

Exstrophy of the bladder is a rare congenital anomaly, with an estimated incidence of 1 in 50,000 live births. It is more common in males (male:female, 5:1 to 6:1) [1]. Currently, exstrophy of the bladder can be diagnosed antenatally with the use of high-resolution real-time ultrasound. With advances in pediatric medicine and reconstructive surgery, the morbidity and mortality associated with this disease has decreased drastically. In the developing world, however, one may come across these patients at an older age, because there is often a delay before they seek medical advice. This was the case with our patient.

The malignant potential of exstrophied bladder mucosa is well known. Chronic irritation and infection leading to metaplastic transformation of the urothelium resulting in malignant changes is the most likely possibility. Adenocarcinoma is the most common type in cases of exstrophy of the bladder, accounting for 95% of cases, whereas squamous cell carcinoma accounts for only 3% to 5% cases [2-4].

The treatment of squamous cell carcinoma of the urinary bladder remains similar to the treatment of transitional cell carcinoma [5]. The gold standard of treatment of squamous cell carcinoma of the bladder is radical cystectomy, with no established guidelines for any adjuvant or neoadjuvant therapy [6, 7]. Radiation therapy is offered to inoperable cases or those who refuse surgery. In our case, radical cystectomy was done. The histopathological examination report confirmed the localized disease; thus, no consideration to chemo-radiation was given.

There are no specific guidelines for follow-up in cases of squamous cell carcinoma. The guidelines for follow-up of bladder cancer in general are applied also for patients with squamous cell carcinoma. Slaton et al. [8] recommended annual screening with a physical examination, measurement of serum chemistry indexes, and chest radiograph for patients with pT1 disease; semiannual evaluation for patients with pT2 disease; and quarterly evaluation for patients with pT3 disease. For the last group, a semiannual computed tomography scan was also recommended.

Repair of the abdominal wall defect created is also an issue when dealing with such cases, because repair under tension may lead to wound dehiscence and accompanying morbidity. The results are cosmetically inferior in such cases. The use of mesh for the repair for abdominal wall defects has been well described. Another method is the use of a tensor fascia lata flap [9]. In our case, because the defect was smaller, it was covered by mobilizing the rectus sheath on both sides, and skin coverage was done with the extended groin flap. The help of plastic surgery colleagues may be sought when closure of the defect is done. We obtained the help of plastic surgeons our case as well.

The prognosis of squamous cell carcinoma of the bladder is reported to be poor with an advanced stage at detection. Kassouf et al. [10] reported a 2-year overall survival of 47.6% with a median recurrence-free survival of 5.1 months.

In conclusion, the fact that exstrophy of the bladder is a predisposing factor for the development of bladder malignancies is well known. Adenocarcinoma is the usual type of malignancy in such cases. Squamous cell carcinoma contributes to only a minority of cases. Treatment of such cases, especially the reconstructive part, is difficult, but good results can be obtained in patients who present early with localized disease, especially when a multidisciplinary approach to treatment is adopted.

Notes

The authors have nothing to disclose.

References

    1. Lattimer JK, Smith MJ. Exstrophy closure: a followup on 70 cases. J Urol 1966;95:356–359.
    1. de Riese W, Warmbold H. Adenocarcinoma in extrophy of the bladder: a case report and review of the literature. Int Urol Nephrol 1986;18:159–162.
    1. Gupta S, Gupta IM. Ectopia vesicae complicated by squamous cell carcinoma. Br J Urol 1976;48:244.
    1. Facchini V, Gadducci A, Colombi L, Ceccarelli P, Lamacchia M, Simi U, et al. Carcinoma developing in bladder exstrophy. Case report. Br J Obstet Gynaecol 1987;94:795–797.
    1. Serretta V, Pomara G, Piazza F, Gange E. Pure squamous cell carcinoma of the bladder in western countries: report on 19 consecutive cases. Eur Urol 2000;37:85–89.
    1. Kochakarn W, Kongchareonsombat W, Tirapanich W. Squamous cell carcinoma of the eviscerated bladder: a case report. J Med Assoc Thai 2001;84:735–737.
    1. Rieder JM, Parsons JK, Gearhart JP, Schoenberg M. Primary squamous cell carcinoma in unreconstructed exstrophic bladder. Urology 2006;67:199.
    1. Slaton JW, Swanson DA, Grossman HB, Dinney CP. A stage specific approach to tumor surveillance after radical cystectomy for transitional cell carcinoma of the bladder. J Urol 1999;162(3 Pt 1):710–714.
    1. Bango Garcia V, Lujan Marco S, Bosquet Sanz M, Gimeno Argente V, Arlandis Guzman S, Alonso Gorrea M, et al. Primary bladder adenocarcinoma in unreconstructed exstrophic bladder. Actas Urol Esp 2009;33:197–199.
    1. Kassouf W, Spiess PE, Siefker-Radtke A, Swanson D, Grossman HB, Kamat AM, et al. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer Center experience. Cancer 2007;110:764–769.

Metrics
Share
Figures

1 / 5

PERMALINK